Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort

BACKGROUND/AIMS: 17β-hydroxysteroid dehydrogenase 13 (HSD17B13) variants were recently reported to have significantly lower odds of non-alcoholic fatty liver disease (NAFLD). This is a two-part study that aimed to evaluate the association of HSD17B13 variants with NAFLD and its histological severity...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Mol Hepatol
المؤلفون الرئيسيون: Ting, Yi-Wen, Kong, Amanda Shen-Yee, Zain, Shamsul Mohd, Chan, Wah-Kheong, Tan, Hwa-Li, Mohamed, Zahurin, Pung, Yuh-Fen, Mohamed, Rosmawati
التنسيق: Artigo
اللغة:Inglês
منشور في: The Korean Association for the Study of the Liver 2021
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8273635/
https://ncbi.nlm.nih.gov/pubmed/33618508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0162
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة